Sarah Cannon Research Institute
Jed Riley has over a decade of experience in financial reporting and analysis, currently serving as the Manager of Financial Reporting/Analysis at Sarah Cannon Research Institute since April 2010, where responsibilities include overseeing monthly financial projections and coordinating annual operating budgets. Previously, Jed held positions such as Senior Financial Analyst and Financial Reporting Analyst at Sarah Cannon, as well as Senior Financial Analyst and Financial Analyst at Quiznos, contributing to consolidated financial reporting, operations reporting, and process improvements. Jed's career began as an Accounting Intern at Safeway Rocky Mountain Federal Credit Union, and educational background includes a Bachelor of Arts in Business Administration with an emphasis in Finance from Wartburg College.
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.